102 related articles for article (PubMed ID: 16643446)
1. Ex vivo modulation of response to prednisolone in childhood acute lymphoblastic leukaemia.
Styczynski J; Wysocki M
Br J Haematol; 2006 May; 133(4):397-9. PubMed ID: 16643446
[TBL] [Abstract][Full Text] [Related]
2. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
4. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
Styczynski J; Koltan A; Wysocki M
Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
[TBL] [Abstract][Full Text] [Related]
5. Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia.
Janiszewska H; Styczynski J; Kolodziej B; Wysocki M; Haus O
Ann Hematol; 2009 Dec; 88(12):1193-8. PubMed ID: 19352661
[TBL] [Abstract][Full Text] [Related]
6. Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells.
Goto H; Yanagimachi M; Kajiwara R; Kuroki F; Yokota S
Leuk Res; 2007 Sep; 31(9):1293-301. PubMed ID: 17306873
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia.
Maung ZT; Reid MM; Matheson E; Taylor PR; Proctor SJ; Hall AG
Br J Haematol; 1995 Sep; 91(1):93-100. PubMed ID: 7577660
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
[TBL] [Abstract][Full Text] [Related]
9. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
10. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
Tissing WJ; Lauten M; Meijerink JP; den Boer ML; Koper JW; Sonneveld P; Pieters R
Haematologica; 2005 Sep; 90(9):1279-81. PubMed ID: 16154856
[TBL] [Abstract][Full Text] [Related]
11. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
Lambrou GI; Vlahopoulos S; Papathanasiou C; Papanikolaou M; Karpusas M; Zoumakis E; Tzortzatou-Stathopoulou F
Leuk Res; 2009 Dec; 33(12):1684-95. PubMed ID: 19450877
[TBL] [Abstract][Full Text] [Related]
12. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
Paugh SW; Bonten EJ; Savic D; Ramsey LB; Thierfelder WE; Gurung P; Malireddi RK; Actis M; Mayasundari A; Min J; Coss DR; Laudermilk LT; Panetta JC; McCorkle JR; Fan Y; Crews KR; Stocco G; Wilkinson MR; Ferreira AM; Cheng C; Yang W; Karol SE; Fernandez CA; Diouf B; Smith C; Hicks JK; Zanut A; Giordanengo A; Crona D; Bianchi JJ; Holmfeldt L; Mullighan CG; den Boer ML; Pieters R; Jeha S; Dunwell TL; Latif F; Bhojwani D; Carroll WL; Pui CH; Myers RM; Guy RK; Kanneganti TD; Relling MV; Evans WE
Nat Genet; 2015 Jun; 47(6):607-14. PubMed ID: 25938942
[TBL] [Abstract][Full Text] [Related]
13. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Ito C; Evans WE; McNinch L; Coustan-Smith E; Mahmoud H; Pui CH; Campana D
J Clin Oncol; 1996 Aug; 14(8):2370-6. PubMed ID: 8708730
[TBL] [Abstract][Full Text] [Related]
14. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
Pui CH
Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
[No Abstract] [Full Text] [Related]
15. Thalidomide increases in vitro sensitivity of childhood acute lymphoblastic leukemia cells to prednisolone and cytarabine.
Czyzewski K; Zaborowska A; Styczyński J
Arch Immunol Ther Exp (Warsz); 2006; 54(5):341-5. PubMed ID: 17031469
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ
Blood; 1998 Jul; 92(1):259-66. PubMed ID: 9639525
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
Lauten M; Fernandez-Munoz I; Gerdes K; von Neuhoff N; Welte K; Schlegelberger B; Schrappe M; Beger C
Pediatr Blood Cancer; 2009 Apr; 52(4):459-63. PubMed ID: 19061214
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R
Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318
[TBL] [Abstract][Full Text] [Related]
19. Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.
Tissing WJ; den Boer ML; Meijerink JP; Menezes RX; Swagemakers S; van der Spek PJ; Sallan SE; Armstrong SA; Pieters R
Blood; 2007 May; 109(9):3929-35. PubMed ID: 17218380
[TBL] [Abstract][Full Text] [Related]
20. The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance.
Ariës IM; Hansen BR; Koch T; van den Dungen R; Evans WE; Pieters R; den Boer ML
Haematologica; 2013 Dec; 98(12):1905-11. PubMed ID: 24142999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
